US Stops Production Of AstraZeneca s COVID-19 Vaccines At A Baltimore-Based Vaccine Maker s Facility AstraZeneca
In a major development, the United States (US) Health and Human Services Department has stopped a Baltimore, Maryland-based vaccine manufacturer from producing doses of AstraZeneca s COVID-19 vaccines,
Livemint.
The development comes days after Emergent BioSolutions had ruined a whopping 15 million doses of the COVID-19 vaccine developed by Johnson & Johnson (J&J) as it accidentally mixed up ingredients from two different vaccines. The mix-up forced the regulator to step in and delay the approval of the output from the facility.
Department has also asked J&J to install a new team to oversee all aspects of the manufacturing of the said facility. Meanwhile, Swedish-British pharmaceutical major AstraZeneca has said that it would work with President Joseph Biden s administration in the US to find an alternative site.
程曉農:2020美國大選——去民主化的範本 ntdtv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ntdtv.com Daily Mail and Mail on Sunday newspapers.